Jens Bjørheim
Directeur Technique/Scientifique/R&D chez ULTIMOVACS ASA
Fortune : - $ au 30/04/2024
Postes actifs de Jens Bjørheim
Sociétés | Poste | Début | Fin |
---|---|---|---|
ULTIMOVACS ASA | Directeur Technique/Scientifique/R&D | - | - |
Historique de carrière de Jens Bjørheim
Anciens postes connus de Jens Bjørheim
Sociétés | Poste | Début | Fin |
---|---|---|---|
AstraZeneca A/S /Denmark/
AstraZeneca A/S /Denmark/ Pharmaceuticals: MajorHealth Technology AstraZeneca A/S sells and distributes pharmaceutical products to the health sector. It specializes within therapy areas of the gastrointestinal diseases, respiratory diseases, cardiovascular diseases, neuroscience, and oncology. The company was founded in 1943 and is headquartered in Copenhagen, Denmark. | Corporate Officer/Principal | 01/01/2013 | 01/01/2016 |
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | Directeur Technique/Scientifique/R&D | 01/01/2006 | 01/01/2008 |
Formation de Jens Bjørheim
University of Oslo | Doctorate Degree |
Statistiques
Internationale
Norvège | 4 |
Danemark | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 2 |
Corporate Officer/Principal | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
ULTIMOVACS ASA | Health Technology |
Entreprise privées | 2 |
---|---|
AstraZeneca A/S /Denmark/
AstraZeneca A/S /Denmark/ Pharmaceuticals: MajorHealth Technology AstraZeneca A/S sells and distributes pharmaceutical products to the health sector. It specializes within therapy areas of the gastrointestinal diseases, respiratory diseases, cardiovascular diseases, neuroscience, and oncology. The company was founded in 1943 and is headquartered in Copenhagen, Denmark. | Health Technology |
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | Health Technology |
- Bourse
- Insiders
- Jens Bjørheim
- Expérience